Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Marcus

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Clinical Nuclear Medicine|August 5, 2022
18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple MyelomaCharles Marcus, David M Schuster, Shahein Holmes Tajmir
Surgical Oncology Clinics of North America|September 24, 2014
Value of imaging in head and neck tumorsAlexander J Antoniou, Charles Marcus, Rathan M Subramaniam
PET Clinics|April 2, 2015
Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid CancerAnthony Ciarallo, Charles Marcus, Mehdi Taghipour, et al.
Clinical Nuclear Medicine|November 7, 2015
Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma: Value to Clinical Assessment and Patient ManagementMehdi Taghipour, Charles Marcus, Pratyusha Nunna, et al.
Clinical Nuclear Medicine|May 24, 2021
Constellation of Von Hippel-Lindau Disease-Related Findings on a 68Ga-DOTATATE PET/CTCharles Marcus, Priya Dayamani John, Monica Giles, et al.
PET Clinics|September 5, 2017
Precision Medicine and PET/Computed Tomography in MelanomaEsther Mena, Yasemin Sanli, Charles Marcus, et al.
PET Clinics|April 2, 2015
PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal CancerRobert M Kwee, Charles Marcus, Sara Sheikhbahaei, et al.
Journal of Medical Imaging and Radiation Oncology|January 16, 2016
The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinomaMehdi Taghipour, Charles Marcus, Joseph Califano, et al.
Clinical Nuclear Medicine|February 2, 2023
Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CTChenxi Wu, Charles Marcus, Yoram Baum, et al.
AJR. American Journal of Roentgenology|June 20, 2020
Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer ManagementCharles Marcus, Peter Butler, Aditya Bagrodia, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Clinical Nuclear Medicine|August 5, 2022
18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple MyelomaCharles Marcus, David M Schuster, Shahein Holmes Tajmir
Surgical Oncology Clinics of North America|September 24, 2014
Value of imaging in head and neck tumorsAlexander J Antoniou, Charles Marcus, Rathan M Subramaniam
PET Clinics|April 2, 2015
Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid CancerAnthony Ciarallo, Charles Marcus, Mehdi Taghipour, et al.
Clinical Nuclear Medicine|November 7, 2015
Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma: Value to Clinical Assessment and Patient ManagementMehdi Taghipour, Charles Marcus, Pratyusha Nunna, et al.
Clinical Nuclear Medicine|May 24, 2021
Constellation of Von Hippel-Lindau Disease-Related Findings on a 68Ga-DOTATATE PET/CTCharles Marcus, Priya Dayamani John, Monica Giles, et al.
PET Clinics|September 5, 2017
Precision Medicine and PET/Computed Tomography in MelanomaEsther Mena, Yasemin Sanli, Charles Marcus, et al.
PET Clinics|April 2, 2015
PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal CancerRobert M Kwee, Charles Marcus, Sara Sheikhbahaei, et al.
Journal of Medical Imaging and Radiation Oncology|January 16, 2016
The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinomaMehdi Taghipour, Charles Marcus, Joseph Califano, et al.
Clinical Nuclear Medicine|February 2, 2023
Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CTChenxi Wu, Charles Marcus, Yoram Baum, et al.
AJR. American Journal of Roentgenology|June 20, 2020
Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer ManagementCharles Marcus, Peter Butler, Aditya Bagrodia, et al.
Pageof 6